Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for endothelial function in adults at increased cardiovascular risk
NL-OMON40596Phase 2Active, not recruiting
- Sponsor
- Servier
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivabradine in endothelial dysfunction, sponsored by Servier. Started Jan 2014; status: active, not recruiting.
02
Drugs
ivabradine
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NL-OMON40596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40596.